These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21254595)

  • 21. Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.
    Kubota K; Kurebayashi H; Miyachi H; Tobe M; Onishi M; Isobe Y
    Bioorg Med Chem; 2011 May; 19(9):3005-21. PubMed ID: 21470866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
    Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
    Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and QSAR of some 3-amino-2-(substituted)aminomethyl-5,6-disubstituted thieno[2,3-d]pyrimidin-4(3H)-ones as novel H1-receptor antagonists.
    Shishoo CJ; Shirsath VS; Rathod IS; Brahmbhatt SB; Pathak US; Jain KS
    Drug Des Discov; 1997 Aug; 15(2):105-15. PubMed ID: 9342553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
    Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
    Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and pharmacological screening of a series of N1-(substituted) aryl-5,7-dimethyl-2-(substituted)pyrido(2,3-d)-pyrimidin-4(3H)-ones as potential histamine H1-receptor antagonists.
    Suhagia BN; Chhabria MT; Makwana AG
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):681-91. PubMed ID: 17252940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
    Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
    Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
    Rose C; Quach TT; Llorens C; Schwartz JC
    Arzneimittelforschung; 1982; 32(9a):1171-3. PubMed ID: 6129863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship studies of CNS agents. Part 1: The Free-Wilson analysis of acute toxicity and sedative effect of some 1,2,3,4-tetrahydro-beta-carbolines.
    Mokrosz JL; Dukat M; Misztal S; Chojnacka-Wójcik E; Tatarczyńska E
    Pharmazie; 1990 Oct; 45(10):765-7. PubMed ID: 2089388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and pharmacological properties of decahydro-5H-pyrido [1',2';5,1] imidazo [3,4-a]-beta-carbolines. Part II.
    Misztal S; Dukat M; Chojnacka-Wójcik E; Tatarczyńska E
    Pol J Pharmacol Pharm; 1988; 40(4):429-33. PubMed ID: 3222182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and pharmacological properties of 9-(N, N-dimethylaminopropyl)-1,2,3,4-tetrahydro-beta-carbolines.
    Misztal S; Wiertek J; Michaluk J
    Pol J Pharmacol Pharm; 1977; 29(6):675-82. PubMed ID: 600866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mutagenesis of the human histamine H1 receptor and design of new antihistamine agents].
    Differding E; Gillard M; Moguilevsky N; Varsalona F; Noyer M; Daliers J; Goldstein S; Neuwels M; Lassoie MA; Guillaume JP; Bascour M; Bollen A; Hénichart JP
    J Pharm Belg; 1996; 51(3):155-60. PubMed ID: 8778348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
    J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of arylbenzofuran H3 receptor antagonists.
    Gfesser GA; Faghih R; Bennani YL; Curtis MP; Esbenshade TA; Hancock AA; Cowart MD
    Bioorg Med Chem Lett; 2005 May; 15(10):2559-63. PubMed ID: 15863316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
    Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
    Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
    Seifert R; Höer A; Offermanns S; Buschauer A; Schunack W
    Mol Pharmacol; 1992 Aug; 42(2):227-34. PubMed ID: 1381043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.
    Fonquerna S; Miralpeix M; Pagès L; Puig C; Cardús A; Antón F; Cárdenas A; Vilella D; Aparici M; Calaf E; Prieto J; Gras J; Huerta JM; Warrellow G; Beleta J; Ryder H
    J Med Chem; 2004 Dec; 47(25):6326-37. PubMed ID: 15566302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents.
    Alagarsamy V; Kavitha K; Rupeshkumar M; Solomon VR; Kumar J; Kumar DS; Sharma HK
    Acta Pharm; 2009 Mar; 59(1):97-106. PubMed ID: 19304562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.